TRANSDERMAL DOPAMINE AGONIST AMELIORATES GASTRIC EMPTYING IN PARKINSON'S DISEASE

被引：0
|
作者：
Sakakibara, R. [1 ]
Doi, H. [2 ]
Shiina, S. [2 ]
Tateno, F. [1 ]
Tateno, H. [1 ]
Kishi, M. [1 ]
Tsuyusaki, Y. [1 ]
Aiba, Y. [1 ]
Yamamoto, T. [3 ]
Yamanishi, T. [4 ]
Uchiyama, T. [4 ]
Shibata, C. [4 ]
机构：
[1] Toho Univ, Sakura Med Ctr, Neurol, Internal Med, Tokyo, Japan
[2] Toho Univ, Sakura Med Ctr, Pharmaceut Unit, Tokyo, Japan
[3] Chiba Univ, Neurol, Chiba, Japan
[4] Dokkyo Med Coll, Continence Ctr, Tokyo, Japan
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
436
引用
收藏
页码：S329 / S330
页数：2
相关论文
共 50 条
  • [1] Transdermal Dopamine Agonist Ameliorates Gastric Emptying in Parkinson's Disease
    Tateno, Hiromi
    Sakakibara, Ryuji
    Shiina, Shunsuke
    Doi, Hirokazu
    Tateno, Fuyuki
    Sato, Mitsutoshi
    Masaka, Tohru
    Kishi, Masahiko
    Tsuyusaki, Yohei
    Aiba, Yosuke
    Ogata, Tsuyoshi
    Suzuki, Yasuo
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (11) : 2416 - 2418
  • [2] A novel dopamine agonist for the transdermal treatment of Parkinson's disease
    Jenner, P
    NEUROLOGY, 2005, 65 (02) : S3 - S5
  • [3] Rotigotine: A novel dopamine agonist for the transdermal treatment of Parkinson's disease
    Zareba, G
    DRUGS OF TODAY, 2006, 42 (01): : 21 - 28
  • [4] Tolerability of switching from an oral dopamine agonist to transdermal rotigotine in Parkinson's disease
    Patton, J.
    Neilson, S.
    Boroojerdi, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 217 - 217
  • [5] Tolerability of switching from an oral dopamine agonist to transdermal rotigotine in Parkinson's disease
    Nausidea, Paul A.
    Neilson, Steven
    Boroojerdi, Babak
    ANNALS OF NEUROLOGY, 2006, 60 : S74 - S74
  • [6] Rotigotine: Transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome
    Splinter, Michele Y.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (02) : 285 - 295
  • [7] Switch from an oral dopamine agonist to rotigotine transdermal patch in Parkinson's disease
    LeWitt, P. A.
    Patton, J. M.
    MacMahon, D. G.
    Jankovic, J.
    MOVEMENT DISORDERS, 2007, 22 : S104 - S104
  • [8] Tolerability of switching from an oral dopamine agonist to transdermal rotigotine in Parkinson's disease
    Whitesides, J.
    Boroojerdi, B.
    JOURNAL OF NEUROLOGY, 2006, 253 : 14 - 14
  • [9] Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease
    Naidu, Y.
    Chaudhuri, K. Ray
    EXPERT OPINION ON DRUG DELIVERY, 2007, 4 (02) : 111 - 118
  • [10] Transdermal Rotigotine: A Clinically Innovative Dopamine-Receptor Agonist for the Management of Parkinson's Disease
    Chen, Jack J.
    Swope, David M.
    Dashtipour, Khashayar
    Lyons, Kelly E.
    PHARMACOTHERAPY, 2009, 29 (12): : 1452 - 1467
12345